SK285970B6 - Použitie N DISACC-(4-(4-chlórfenyl)benzyl)A82846Balebo teikoplanínu na prípravu liečiva na dlhodobú prevenciu infekcií Streptococcus pneumoniae a farmaceutické kompozície s ich obsahom - Google Patents

Použitie N DISACC-(4-(4-chlórfenyl)benzyl)A82846Balebo teikoplanínu na prípravu liečiva na dlhodobú prevenciu infekcií Streptococcus pneumoniae a farmaceutické kompozície s ich obsahom Download PDF

Info

Publication number
SK285970B6
SK285970B6 SK1557-2001A SK15572001A SK285970B6 SK 285970 B6 SK285970 B6 SK 285970B6 SK 15572001 A SK15572001 A SK 15572001A SK 285970 B6 SK285970 B6 SK 285970B6
Authority
SK
Slovakia
Prior art keywords
benzyl
chlorophenyl
disacc
pneumoniae
teicoplanin
Prior art date
Application number
SK1557-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK15572001A3 (sk
Inventor
Thomas Reeves Parr
Margaret Mary Wasilewski
Michael Lee Zeckel
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SK15572001A3 publication Critical patent/SK15572001A3/sk
Publication of SK285970B6 publication Critical patent/SK285970B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SK1557-2001A 1999-05-03 2000-04-19 Použitie N DISACC-(4-(4-chlórfenyl)benzyl)A82846Balebo teikoplanínu na prípravu liečiva na dlhodobú prevenciu infekcií Streptococcus pneumoniae a farmaceutické kompozície s ich obsahom SK285970B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03
PCT/US2000/008737 WO2000066144A2 (en) 1999-05-03 2000-04-19 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections

Publications (2)

Publication Number Publication Date
SK15572001A3 SK15572001A3 (sk) 2003-05-02
SK285970B6 true SK285970B6 (sk) 2007-12-06

Family

ID=22453188

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1557-2001A SK285970B6 (sk) 1999-05-03 2000-04-19 Použitie N DISACC-(4-(4-chlórfenyl)benzyl)A82846Balebo teikoplanínu na prípravu liečiva na dlhodobú prevenciu infekcií Streptococcus pneumoniae a farmaceutické kompozície s ich obsahom

Country Status (29)

Country Link
EP (1) EP1175222B1 (de)
JP (1) JP2002543146A (de)
KR (1) KR100757165B1 (de)
CN (1) CN1349407A (de)
AR (1) AR023827A1 (de)
AT (1) ATE284702T1 (de)
AU (1) AU774647B2 (de)
BR (1) BR0010244A (de)
CA (1) CA2372790A1 (de)
CZ (1) CZ296127B6 (de)
DE (1) DE60016734T2 (de)
DZ (1) DZ3039A1 (de)
EA (1) EA004295B1 (de)
HK (1) HK1044707B (de)
HR (1) HRP20010808A2 (de)
HU (1) HUP0200940A3 (de)
IL (2) IL145582A0 (de)
MY (1) MY123542A (de)
NO (1) NO20015291L (de)
NZ (1) NZ514467A (de)
PE (1) PE20010292A1 (de)
PL (1) PL353444A1 (de)
SK (1) SK285970B6 (de)
SV (1) SV2002000065A (de)
TR (1) TR200103211T2 (de)
TW (1) TWI255716B (de)
UA (1) UA73937C2 (de)
WO (1) WO2000066144A2 (de)
ZA (1) ZA200108013B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
US8420592B2 (en) * 2008-08-30 2013-04-16 The Medicines Company Methods of treatment using single doses of oritavancin
EP2969004A4 (de) 2013-03-15 2016-09-21 Melinta Therapeutics Inc Verfahren zur behandlung von infektionen bei übergewichtigen und adipösen patienten mithilfe von antibiotika
US20160206688A1 (en) * 2013-08-26 2016-07-21 The Medicines Company Methods for treating bacteremia and osteomyelitis using oritavancin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
JP2002543146A (ja) 2002-12-17
WO2000066144A3 (en) 2001-04-12
AR023827A1 (es) 2002-09-04
AU4329200A (en) 2000-11-17
CA2372790A1 (en) 2000-11-09
NO20015291L (no) 2001-12-17
HK1044707A1 (en) 2002-11-01
CZ296127B6 (cs) 2006-01-11
BR0010244A (pt) 2002-01-08
TR200103211T2 (tr) 2002-02-21
DE60016734D1 (de) 2005-01-20
PE20010292A1 (es) 2001-03-07
UA73937C2 (en) 2005-10-17
EA004295B1 (ru) 2004-02-26
MY123542A (en) 2006-05-31
IL145582A (en) 2008-12-29
HUP0200940A2 (en) 2002-08-28
EP1175222A2 (de) 2002-01-30
DZ3039A1 (fr) 2004-03-27
ZA200108013B (en) 2003-03-26
EP1175222B1 (de) 2004-12-15
KR20020008173A (ko) 2002-01-29
WO2000066144A2 (en) 2000-11-09
KR100757165B1 (ko) 2007-09-07
SK15572001A3 (sk) 2003-05-02
PL353444A1 (en) 2003-11-17
HK1044707B (zh) 2005-09-30
NO20015291D0 (no) 2001-10-29
IL145582A0 (en) 2002-06-30
CN1349407A (zh) 2002-05-15
HUP0200940A3 (en) 2002-10-28
AU774647B2 (en) 2004-07-01
NZ514467A (en) 2005-01-28
SV2002000065A (es) 2002-12-02
HRP20010808A2 (en) 2002-12-31
EA200101171A1 (ru) 2002-04-25
ATE284702T1 (de) 2005-01-15
CZ20013949A3 (cs) 2002-07-17
TWI255716B (en) 2006-06-01
DE60016734T2 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
ES2210274T3 (es) Derivados de antibioticos glicopeptidicos.
ES2274525T3 (es) Derivados de antibioticos glicopeptidos.
CA2699550C (en) Method of inhibiting clostridium difficile by administration of oritavancin
DK2337575T3 (en) A method of treatment with single doses of oritavancin
CA2664444C (en) Use of oritavancin for prevention and treatment of anthrax
CN111093625A (zh) 达托霉素制剂
WO2001056994A1 (en) Integrin antagonists
SK285970B6 (sk) Použitie N DISACC-(4-(4-chlórfenyl)benzyl)A82846Balebo teikoplanínu na prípravu liečiva na dlhodobú prevenciu infekcií Streptococcus pneumoniae a farmaceutické kompozície s ich obsahom
MXPA01011161A (es) Dosis mensuales para el tratamiento de infecciones por streptococcus pneumoniae

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090419